Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis

NCT03007004 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis Patients With Digital Ulcers

Interventions

DRUG: Botulinum toxin type B (2500 units / vial)
DRUG: Physiological saline

Sponsor

Gunma University